Skip to Content

Hartford Healthcare HLS IA HIAHX

Medalist Rating as of | See Hartford Funds Investment Hub
  • NAV / 1-Day Return 16.49  /  −0.06 %
  • Total Assets 133.6 Mil
  • Adj. Expense Ratio
    0.910%
  • Expense Ratio 0.910%
  • Distribution Fee Level Average
  • Share Class Type Institutional
  • Category Health
  • Investment Style Large Growth
  • Min. Initial Investment
  • Status Open
  • TTM Yield 0.43%
  • Turnover 28%

USD | NAV as of Apr 19, 2024 | 1-Day Return as of Apr 19, 2024, 10:13 PM GMT+0

Morningstar’s Analysis HIAHX

Will HIAHX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

A sound investment process and strong management team underpin Hartford Healthcare HLS IA's Morningstar Medalist Rating of Silver.

null Morningstar Manager Research

Morningstar Manager Research

Summary

The strategy charges fees in line with its similarly distributed peers, priced within the middle quintile.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings HIAHX

  • Current Portfolio Date
  • Equity Holdings
  • Bond Holdings
  • Other Holdings
  • % Assets in Top 10 Holdings 43.3
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Eli Lilly and Co

10.92 15.5 Mil
Healthcare

UnitedHealth Group Inc

6.79 9.6 Mil
Healthcare

Merck & Co Inc

6.37 9.0 Mil
Healthcare

Danaher Corp

3.90 5.5 Mil
Healthcare

Stryker Corp

2.83 4.0 Mil
Healthcare

Boston Scientific Corp

2.80 4.0 Mil
Healthcare

Thermo Fisher Scientific Inc

2.51 3.6 Mil
Healthcare

HCA Healthcare Inc

2.51 3.5 Mil
Healthcare

AbbVie Inc

2.39 3.4 Mil
Healthcare

Vertex Pharmaceuticals Inc

2.32 3.3 Mil
Healthcare